Cytokinin activity in the culture medium of four pathogenic strains of Corynebacterium fascians varied from 168 to 0.4 jsg of kinetin (6-furfurylaminopurine) equivalents per liter, as compared to 0.2 in an avirulent control. NA-Isopentenyladenine was the predominant cytokinin in the medium of all five strains, and its increased production was correlated with the degree of pathogenicity; however, the virulent strains also produced 8-13 times more cis-zeatin [6(4-hydroxy-3-methyl-cis-2-butenylamino)purineJ than the avirulent strain. as 644-hydroxy-3-methyl-cis-2-butenylamino)9-0-D-ribofuranosylpurine, 6q3methyl-2-butenylamino.9-j-D-ribofuranosylpurine, and their 2-methylthio derivatives. The fifth cytokinin was tentatively identified as 6(4-hydroxy-3-methyl-trans-2-butenylamino)9-#-D-ribofuranosylpurine. Ribosyl-cis-zeatin was 3fold higher and N6-isopentenyladenosine was correspondingly lower in the plasmid-containing strains than in the plasmidless control. Because the entire syndrome of fasciation caused by infection can be induced with synthetic cytokinins, the disease would appear to be caused by plasmid-induced high rates of cytokinin production by the bacteria. Corynebacterium fascians causes fasciation disease or witches' broom in dicotyledonous plants. The disease is characterized by release of apical dominance and outgrowth of lateral buds, which gives rise to the characteristic witches' broom syndrome (1). The symptoms of the disease can be duplicated by treatment of seeds or seedlings with cytokinins, indicating that it may be caused by cytokinins produced by the microbe (2). From C. fascians culture medium four cytokinins, 6-(3-methyl-2-butenylamino)purine. (i6Ade), 6-(4-hydroxy-3-methyl-cis-2-butenylamino)purine (c-io6Ade), 6-(4-hydroxy -3-methyl-cis -2-butenylamino) -2-methylthiopurine (ms2-c-io6Ade), and 6-methylaminopurine (m6Ade),.have been characterized, and three additional cytokinins, 6-(4-hydroxy-3-methyl-trans-2-butenylamino)purine (t-io6Ade), 6-(4-hydroxy-3-methyl-2-butenylamino)-9-/3-D-ribofuranosylpurine (io6A), and 6-(3-methyl-2-butenylamino)-9-f3-D-ribofuranosylpurine (i6A), have been tentatively identified (3-6). The tRNA of the bacterium has been reported to contain several cytokinins (7-9), but only c-io6A has been rigorously identified (10). Biosynthesis of the i6A moiety in tRNA involves the transfer of isopentenyl from A2-isopentenyl pyrophosphate to specific adenosine residues in preformed tRNA (11, 12) , and it has been proposed that i6Ade and other free cytokinins in the culture medium derive from tRNA degradation. The existence of alternative pathways is probable, as suggested by the in vitro synthesis of free i6Ade from AMP and A2-isopentenyl pyrophosphate recently achieved with an enzyme preparation from Dictyostelium (13).
butenylamino)9-#-D-ribofuranosylpurine. Ribosyl-cis-zeatin was 3fold higher and N6-isopentenyladenosine was correspondingly lower in the plasmid-containing strains than in the plasmidless control. Because the entire syndrome of fasciation caused by infection can be induced with synthetic cytokinins, the disease would appear to be caused by plasmid-induced high rates of cytokinin production by the bacteria. Corynebacterium fascians causes fasciation disease or witches' broom in dicotyledonous plants. The disease is characterized by release of apical dominance and outgrowth of lateral buds, which gives rise to the characteristic witches' broom syndrome (1) . The symptoms of the disease can be duplicated by treatment of seeds or seedlings with cytokinins, indicating that it may be caused by cytokinins produced by the microbe (2) . From C. fascians culture medium four cytokinins, 6-(3-methyl-2-butenylamino)purine. (i6Ade), 6 -(4-hydroxy-3-methyl-cis-2-butenylamino)purine (c-io6Ade), 6 -(4-hydroxy -3-methyl-cis -2-butenylamino) -2-methylthiopurine (ms2-c-io6Ade), and 6-methylaminopurine (m6Ade),.have been characterized, and three additional cytokinins, 6-(4-hydroxy-3-methyl-trans-2-butenylamino)purine (t-io6Ade), 6 -(4-hydroxy-3-methyl-2-butenylamino)-9-/3-D-ribofuranosylpurine (io6A), and 6-(3-methyl-2-butenylamino)-9-f3-D-ribofuranosylpurine (i6A), have been tentatively identified (3) (4) (5) (6) . The tRNA of the bacterium has been reported to contain several cytokinins (7) (8) (9) , but only c-io6A has been rigorously identified (10) .
Biosynthesis of the i6A moiety in tRNA involves the transfer of isopentenyl from A2-isopentenyl pyrophosphate to specific adenosine residues in preformed tRNA (11, 12) , and it has been proposed that i6Ade and other free cytokinins in the culture medium derive from tRNA degradation. The existence of alternative pathways is probable, as suggested by the in vitro synthesis of free i6Ade from AMP and A2-isopentenyl pyrophosphate recently achieved with an enzyme preparation from Dictyostelium (13) .
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This report deals with the kinds and quantities of cytokinins released into culture media and present in tRNA of five strains of C. fascians, ranging from highly virulent to avirulent, and examines relationships of the presence of plasmids to cytokinin production and to pathogenicity.
MATERIALS AND METHODS
Origin and Growth of C. fascians Strains. Strain MW2 was isolated by and obtained from M. A. Rahman (University of Alexandria, Egypt). Cultures of Cf2 and C616, originating from the Burkholder Collection at Cornell University, were supplied by J. P. Helgeson (University of Wisconsin). Strain Cf1, also originating from the Burkholder Collection, was obtained from K. V. Thimann in 1965, and has been subeultured in our laboratory since that time. Strain Cf15 was provided by M. Starr (University of California-Davis). Cultures were grown routinely at 25°C on Bacto nutrient broth and nutrient agar or on minimal salts/thiamine medium with 0.5% (wt/vol) glucose. For isolation of cytokinin and tRNA, the bacteria were cultured in defined synthetic medium as described (3) , and as modified (5) in 1-liter or 10-liter batches at 250C for 4 days, at which time they reached early stationary phase.
Virulence Tests. Virulence was determined essentially as described by Lacey (14) . Seeds of Pisum sativum L. var. Dwarf Grey Sugar were soaked for 2 days in sterile water, then immersed in a few milliliters of a 25-hr culture of bacteria for 5 mm and planted in sterile vermiculite. Within a week, seedlings treated with virulent strains developed lateral shoots, whereas untreated seeds and those exposed to avirulent strains developed single main shoots Determination of Number of Plasmids. Cultures (36 hr) grown in minimal salts/thiamine plus glucose, 0.05% (wt/vol) yeast extract, and 0.1% (wt/vol) peptone were diluted with the same medium to 0.1 A W unit and incubated for an additional hour with 0.25% (wt/vol) glycine.
[3H]Adenosine (10 ,Ci/ml; 1 Ci = 3.7 X 1010 becquerels) was added in three portions at 1-hr intervals. The cells were incubated for one more hour and harvested by centrifugation at 10,000 X g for 20 min. Lysates were prepared by the method of Sharp et al. (15) ; 0.1-0.2 ml of lysate was layered on 5-20% (wt/vol) sucrose gradients prepared in 300 mM NaOH/500 mM NaCI/20 mM EDTA.
Abbreviations: kinetin, 6-furfurylaminopurine; KE, kinetin equivalent; TMS, trimethylsilyl; zeatin, io6Ade; c-or t-io6A, 6-(4-hydroxy-3-methyl-cis or trans-2-butenylamino)-9-,/-D-ribofuranosylpurine; cor t-io6Ade, 6-(4-hydroxy-3-methyl-cis or trans-2-butenylamino)-purine; i6A, 6-(3-methyl-2-butenylamino)-9-fl-D-ribofuranosylpurine; i6Ade, 6-(3-methyl-2-butenylamino)purine; ms2-c-io6A, 6 -(4-hydroxy-3-methyl-cis -2-butenylamino)-2-methylthio-9 -f3-D-ribofuranosylpurine; ms2-c-io6Ade, 6-(4-hydroxy-3-methyl-cis-2-butenylamino)-2-methylthiopurine; ms2i6A, 6-(3-methyl-2-butenylamino)-2-methylthio-9-f3-D-ribofuranosylpurine; ms2i6Ade, 6-(3-methyl-2-butenyl-amino)-2-methylthiopurine; m6Ade, 6-methylaminopurine.
Proc. Nati. Acad. Sci. USA 77 (1980) The gradients were centrifuged at 115,000 X g for 55 min in an SW41 rotor. The number of plasmids was determined from the number of radioactive peaks below the major peak of radioactivity in the alkaline sucrose gradients and confirmed by electrophoresis of purified plasmids in agarose gels by the method of Meyers et al. (16) . Plasmid DNA was isolated by the technique of Currier (17) modified as suggested by E. W. Nester.
Purification of Cytokinins from Culture Medium. The cells were separated from the culture medium by centrifugation at 5700 X g for 10 min. Cytokinins were purified from the supernatant fraction as described (5) . Cytokinin activity was determined by the tobacco callus bioassay (18, 19) and is expressed as ,ug of kinetin equivalents (KE) [,ug of kinetin (6-furfurylaminopurine) required -to give the same growth response as the test sample under the specified bioassay conditions].
Isolation and Identification of Cytokinins from tRNA. The harvested cells were suspended in 5 vol of 0.1 M Tris-HCI (pH 7.3), incubated with 0.02% (wt/vol) lysozyme for 60 min at 220C, mixed with 0.5% (wt/vol) sodium lauryl sulfate, and ruptured by two passages through a French press (840-1260 kg/cm2). tRNA was purified as described (20) and hydrolyzed to ribonucleosides (21) . Cytokinins were separated and their activities were determined as described (22) . The UV spectra of cytokinin-active ribonucleosides in ethanol were determined on a Beckman model 25 spectrophotometer. The quantities of cytokinin were calculated from the Xma, absorbances and the known extinction coefficients of the ribonucleosides (23) . Purified cytokinin-active ribonucleosides were trimethylsilylated as described (18) . Gas/liquid chromatophy-mass spectrometry of trimethylsilylated cytokinins was performed on a Varian aerograph series 2700 gas chromatograph coupled via a glass jet separator to a model 21-491B DuPont Instruments mass spectrometer equipped with oscillograph. Two microliters of trimethylsilylated samples were chromatographed on a coil Pyrex column (180 X 0.2 cm) packed with 1% (vol/wt) OV-17 on Gas Chrom Q with He at a flow rate of 30 ml/min. The stereoisomers of trimethylsilylated 6-(4-hydroxy-3-methyl-2-butenylamino)-2-methylthio-9 -,-D-ribofuranosylpurine (ms2io6A) were separated by isothermal chromatography at 260°C. The trimethylsilylated c-io6A, i6A, and 6-(3-methyl-2 -butenylamino) -methylthio*- 9 Table 2 ) and also in Cf cultures (3, 5) . The quantity of i6Ade increased with the degree of pathogenicity, from 2 ,ug of KE per liter in the avirulent cultures without a plasmid to 24 ,ug of KE per liter in the highly virulent strain MW2, as measured on purified preparations was -10 times more abundant in media of the virulent strains than in that of the avirulent Cf16 strain. In cultures of the weakly virulent Cf15, io6Ade was about half as active as i6Ade, and, therefore, allowing for differences in specific activity, the more abundant of the two, but in culture media of the more virulent strains (Cf1 and MW2) the io6Ade accounted for only a minor part of the total cytokinin activity. The other four detected cytokinins (Table 2) contributed even less to the total biological activity. ms2-c-io6Ade activity was 10-to 16-fold higher in the strains with plasmids. Cytokinin Activity in tRNA Hydrolysates. The kinds and quantities of cytokinin-active ribonucleosides in tRNA from each of these four strains were also determined ( Table 3 ). The total yields of cells in the 4-day-old cultures used for preparations of tRNA and their yields of tRNA did not differ significantly for the four strains. In each case, bioassays of ethyl acetate-soluble ribonucleosides from the tRNA, chromatographed on Sephadex LH-20 columns (30 g, 1.9 X 42.0 cm) in 35% (vol/vol) ethanol, revealed three peaks of cytokinin activity, fractions 3, 5, and 8, corresponding to the elution positions of io6A, i6A plus ms2io6A, and ms2i6A, respectively. Cytokinins in these three active fractions for each of the four strains were further purified and identified. Fraction Fig. 2A) , thus proving the structure of II to be 6-(4-hydroxy-3-methylcis-2-butenylamino)-9-3-D-ribofuranosylpurine. with elution volumes corresponding to those of i6A and ms2io6A, respectively. The UV spectrum of III was typical of N6-alkyl adenosines with Xmax at 268 nm. Gas/liquid chromatography of trimethylsilylated III gave a peak with the same retention time (6.9 min) as synthetic i6A(TMS)3. The mass spectrum of this peak exhibited the prominent m/e values 551 (M+), 536, 318, 232, and 203, which are characteristic of i6A(TMS)3 (Fig.  2B) . From these data, III was assigned the structure 6-(3-methyl-2-butenylamino)-9-3-D-ribofuranosylpurine.
Compound IV had UV absorption maxima at 244 and 283 nm, characteristic of N6,2-disubstituted adenosines. The mass spectrum of a prominent peak of trimethylsilylated IV in gas/liquid chromatography gave abundant ions at m/e 685 (M+), 670, 595, 554, 529, 452, 366, and 336, typical of ms2io6A(TMS)4 (Fig. 2C) . The 4.2-min retention time of this peak was identical with that of authentic cis isomer of ms2io6A(TMS)4 and was distinctly less than the 4.7-min retention time of the trans isomer. From these data, IV was assigned the structure, 6A(4-hydroxy-3-methyl-cis-2-butenylamino)-2-methylthio-9-3-D-ribofuranosylpurine.
Fraction 8 (V) exhibited only weak cytokinin activity. Its UV spectrum resembled that of ms2i6A, with Xmax at 282-283 nm and a shoulder at 245 nm. Gas/liquid chromatography of trimethylsilylated V gave a number of prominent peaks, the retention time of one of which was 10.6 min and identical with that of ms2i6A(TMS)3. The mass spectrum of this peak was characteristic of ms2i6A(TMS)3, with peaks at m/e values 597 (M+), 582, 554, 529, 364, 278, and 249 (Fig. 2D) . These data show that V, the cytokinin-active component of fraction
The tRNA of each of the four examined C. fascians strains contained all five identified cytokinins ( Table 3 ). The total cytokinin content in mole % did not differ markedly between the strains, but the cytokinin composition was very different in the presence and absence of plasmids. In each of the plasmid-containing strains the abundance of the different cytokinins decreased in the order ms2-c-io6A, c-io6A, i6A, mS2i6A, and t-io6A, but in the plasmidless strain Cf16, ms2i6A was predominant and was followed in order by i6A, ms2-c-io6A, c-io6A, and t-io6A. In each of the strains with a plasmid the cytokinins with a 4-hydroxylated isopentenyl side chain were more than twice as abundant as cytokinins with an unsubstituted isopentenyl side chain, whereas in the strain without a plasmid this ratio was the reverse. In terms of total cytokinin activity in tRNA hydrolysates as measured in the tobacco bioassay, the observed differences between plasmid and plasmidless strains were less than between strains which contained plasmids. Plasmids. All four pathogenic strains contained one or more plasmids; the first three (MW2, Cf1, and Cf2) contained a large (Mr z 108) plasmid, but the fourth, very weakly pathogenic strain (Cf15), contained only a smaller plasmid. Small plasmids also have been found in Cf1 and may be present in MW2. The avirulent strain (Cf16) contained no detectable plasmid but still may contain some extrachromosomal DNA. It appears from these data that pathogenicity is associated with the presence of plasmids, and in strains tested so far a high degree of virulence was associated with the presence of a large plasmid. In MW2, loss of virulence was associated with loss of its large plasmid.
DISCUSSION
All cytokinin-active bases and ribonucleosides expected from degradation of tRNA can be recovered from the culture medium of all strains of C. fascians examined. The very low or undetectable content of mA6A and ms2i6Ade can be attributed to loss of these substances in the purification by Dowex chromatography. Improved yields of mS2i6A and a detectable amount of ms2i6Ade were obtained from culture medium of MW2 when BioRex-70, a weak cation exchange resin, was used instead of the usual Dowex-50 resin.
The clear precursor-product relationship between cytokinin ribonucleosides in tRNA and the presence of free cvtokininactive bases and ribonucleosides in the culture medium suggests that tRNA may serve as one primary source of cytokinins released by C. fascians, as proposed earlier (5, 6, 8) . The relatively constant relationship between quantities of io6A and ms2io6A in tRNA and the quantities of these ribonucleosides and derived bases in the culture medium of the virulent strains is consistent with this view. However, the extreme increase in free i6Ade associated with pathogenicity points to an alternative biosynthetic pathway for this cytokinin. An alternative pathway of i6Ade from AMP and A2-isopentenyl pyrophosphate occurs in Dictyostellum (13) . Both the marked increase in i6Ade content in the culture medium and the presence of high contents of hydroxylated isopentenyladenine derivatives (cis-and transzeatin and their derivatives) in the culture medium or in tRNA (or in both) of C. fascians appear to be dependent on the presence of plasmids. Similarly, high cytokinin activity in the culture medium and the presence of zeatin ribonucleotides in the tRNA have been correlated with pathogenicity and with the presence of plasmids in Agrobacterium tumefaciens (24, 25) . High contents of zeatin or its derivatives are also present in other organisms that cause overgrowths in plants, such as mycorrhizal fungi (26) , gall-forming insects (27) (28) (29) , etc. (29) , even though hydroxylated isopentenyladenines normally are found neither in fungi nor in animals (29, 30) . These results raise the question of whether DNA that codes for high cytokinin production and zeatin biosynthesis in prokaryotic plant pathogens, and in the case of A. tumefaciens may be transmitted to serve this function in host tissue, is of prokaryotic origin or has been acquired by the pathogens from plants during evolution. They also raise the question of whether gall-forming insects and other eukaryotic pathogens which cause overgrowths in plants may possess DNA originally derived from plants.
